264 related articles for article (PubMed ID: 23537059)
1. Subacute cutaneous lupus erythematosus in the course of rheumatoid arthritis: a relationship with TNF-α antagonists and rituximab therapy?
Lis-Święty A; Brzezińska-Wcisło L; Widuchowska M; Kucharz E
Immunopharmacol Immunotoxicol; 2013 Jun; 35(3):443-6. PubMed ID: 23537059
[TBL] [Abstract][Full Text] [Related]
2. TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists.
Williams VL; Cohen PR
Int J Dermatol; 2011 May; 50(5):619-25. PubMed ID: 21506984
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced lupus erythematosus.
Vedove CD; Del Giglio M; Schena D; Girolomoni G
Arch Dermatol Res; 2009 Jan; 301(1):99-105. PubMed ID: 18797892
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis: results from a randomized controlled trial.
Greenwald MW; Shergy WJ; Kaine JL; Sweetser MT; Gilder K; Linnik MD
Arthritis Rheum; 2011 Mar; 63(3):622-32. PubMed ID: 21360491
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced lupus: an update on its dermatologic aspects.
Marzano AV; Vezzoli P; Crosti C
Lupus; 2009 Oct; 18(11):935-40. PubMed ID: 19762393
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced lupus erythematosus.
Marzano AV; Tavecchio S; Menicanti C; Crosti C
G Ital Dermatol Venereol; 2014 Jun; 149(3):301-9. PubMed ID: 24819757
[TBL] [Abstract][Full Text] [Related]
7. TNF-inhibitor induced lupus in a patient treated with adalimumab for rheumatoid arthritis.
Lieberman MR; Liebman TN; Alapati U; Khachemoune A
Dermatol Online J; 2014 Dec; 21(2):. PubMed ID: 25756476
[TBL] [Abstract][Full Text] [Related]
8. Subacute cutaneous lupus erythematosus induced by terbinafine: case report and review of literature.
Lorentz K; Booken N; Goerdt S; Goebeler M
J Dtsch Dermatol Ges; 2008 Oct; 6(10):823-7, 823-8. PubMed ID: 18564209
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic agents for patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor-alpha antagonists.
Isaacs JD
Expert Opin Biol Ther; 2009 Dec; 9(12):1463-75. PubMed ID: 19916731
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart.
Marzano AV; Lazzari R; Polloni I; Crosti C; Fabbri P; Cugno M
Br J Dermatol; 2011 Aug; 165(2):335-41. PubMed ID: 21564069
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced lupus in anti-TNF-alpha therapy and its treatment with rituximab.
Diaz JC; Vallejo S; Cañas CA
Rheumatol Int; 2012 Oct; 32(10):3315-7. PubMed ID: 21881980
[TBL] [Abstract][Full Text] [Related]
12. Golimumab-exacerbated subacute cutaneous lupus erythematosus.
Wilkerson E; Hazey MA; Bahrami S; Callen JP
Arch Dermatol; 2012 Oct; 148(10):1186-90. PubMed ID: 23069957
[TBL] [Abstract][Full Text] [Related]
13. Terbinafine-induced subacute cutaneous lupus erythematosus.
Bonsmann G; Schiller M; Luger TA; Ständer S
J Am Acad Dermatol; 2001 Jun; 44(6):925-31. PubMed ID: 11369902
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of a third tumor necrosis factor-α-blocking agent compared with rituximab after failure of 2 TNF-blocking agents in rheumatoid arthritis.
Blom M; Kievit W; Donders AR; den Broeder AA; Straten VH; Kuper I; Visser H; Jansen TL; Brus HL; Branten AJ; van de Laar MA; van Riel PL
J Rheumatol; 2011 Nov; 38(11):2355-61. PubMed ID: 21885487
[TBL] [Abstract][Full Text] [Related]
15. Subacute lupus erythematosus during treatment with golimumab for seronegative rheumatoid arthritis.
Brunasso AM; Aberer W; Massone C
Lupus; 2014 Feb; 23(2):201-3. PubMed ID: 24356614
[TBL] [Abstract][Full Text] [Related]
16. Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis.
Vallerskog T; Heimbürger M; Gunnarsson I; Zhou W; Wahren-Herlenius M; Trollmo C; Malmström V
Arthritis Res Ther; 2006; 8(6):R167. PubMed ID: 17092341
[TBL] [Abstract][Full Text] [Related]
17. Acebutolol-induced subacute cutaneous lupus erythematosus.
Fenniche S; Dhaoui A; Ammar FB; Benmously R; Marrak H; Mokhtar I
Skin Pharmacol Physiol; 2005; 18(5):230-3. PubMed ID: 16015021
[TBL] [Abstract][Full Text] [Related]
18. Leflunomide in subacute cutaneous lupus erythematosus - two sides of a coin.
Suess A; Sticherling M
Int J Dermatol; 2008 Jan; 47(1):83-6. PubMed ID: 18173611
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of drug-induced subacute cutaneous lupus erythematosus.
Lowe GC; Henderson CL; Grau RH; Hansen CB; Sontheimer RD
Br J Dermatol; 2011 Mar; 164(3):465-72. PubMed ID: 21039412
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced subacute cutaneous lupus erythematosus related to doxycycline.
Miller KK; Chu J; Patel R; Kamino H
Dermatol Online J; 2011 Oct; 17(10):3. PubMed ID: 22031629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
